Well considering the whole company is only worth 35 million dollars to get enough money to complete just the head and neck cancer phase 2/3 trial will be worth more than the entire company. Seems a bit absurd. So we need to dilute over 100% just to maybe finish one trial. This just demonstrates how absurdly undervalued we are at this point in my opinion.